Wednesday, September 13th | |
| 08.00-18.00 | Registration |
| 08.30-12.00 | International Symposium for Perfusionists and Allied Health Professionals |
| 12.00-12.45 | VAD Journal Editorial Board Meeting |
| 13.00-19.15 | Brano Heart Failure Forum Scentific Sessions |
| 20.00-22.00 | Evening Reception |
Thursday, September 14th | |
| 08.00-18.00 | Registration |
| 08.15-19.00 | Brano Heart Failure Forum Scientific Sessions |
| 20.00-23.00 | Gala Dinner |
Friday, September 15th | |
| 08.00-18.00 | Registration |
| 08.30-19.15 | Brano Heart Failure Forum Scientific Sessions |
| 20.00-23.00 | Farewell Dinner |
| 08.30-10.00 | Session 1 - Important Elements of Succesful ECMO Program Moderator: R. Radovancevic, B. Sax |
| 08.30-08.40 | Start-Up of a Perfusion Education Program E. Solberg (Houston, USA) |
| 08.40-08.50 | Transporting ECMO patient: Pitfalls and Troubleshooting I. Banjac (Houston, USA) |
| 08.50-09.00 | Bacabal (IVC/SVC junction) cannulation with a peripheral drainage cannula on ECMO K. San Miguel (Houston, USA) |
| 09.00-09.10 | Reducing Gaseous Microemboli S. Kulic (Belgrade, SRB) |
| 09.10-09.20 | ECMO in Primary Graft Dysfunction - How Long? R. Mrkonjic (Zagreb, CRO) |
| 09.20-09.30 | Anticoagulation Management for Patients with Extracorporeal Membrane Oxygenation Therapy: Theory vs. Reality J. Osario (Houston, USA) |
| 09.30-10.00 | Discussion |
| 10.00-10.30 | Coffee Break |
| 10.30-12.00 | Session 2 - Important Elements of Succesful End Stage Heart Failure Program Moderator: I. Hartyánszky, T. Myers |
| 10.30-10.40 | Advances in HF Treatments: Education for Staff M. Clark (Houston, USA) |
| 10.40-10.50 | Organizing Mechanical Circulatory Support: Personnel Requirements S. Klesnik (Houston, USA) |
| 10.50-11.00 | Pitfalls in Condacting Clinical Trials C. Patel (Houston, USA) |
| 11.00-11.10 | Bloodless Cardiac Surgery Program S. Eaton (Los Angeles, USA) |
| 11.10.11.20 | Awake Off-Pump Coronary Artery Bypass Grafting in Elderly Heart failure Patient with Interstitial Lung Disease Z. Demirozu (Istanbul, TUR) |
| 11.20-11.30 | Short term Percutaneous Mechanical Circulatory Support in Cardiac Surgery N. Ristic (Belgrade, SRB) |
| 11.30-12.00 | Discussion |
| 12.00-13.00 | Lunch Break |
| 13.00-13.10 | Brano Forum Opening Session Welcome address - Congress Chair |
| 13.00-13.10 | Welcome I. Gregoric, B. Merkely, B. Vrtovec, I. Hartyánszky, B. Sax, R. Radovancevic |
| 13.10-14.00 | Key Note Presentations |
| 13.10-13.35 | Establishing a Heart Failure Center at UTHealth G. Colasurdo (Houston, USA) |
| 13.35-14.00 | Semmelweis University B. Merkely (Budapest, HUN) |
| 14.00-15.00 | Session 1 - Acute Mechanical Circulatory Support Moderator B. Kar Panel: A. El-Banayosy, G. Nersesian, F. Papalardo, D. Zimpfer, B. Biocina |
| 14.00-14.05 | Establishing a Postcardiotomy Cardiogenic Shock Network: A Comprehensive Rationale and Outcomes A. El-Banayosy (Oklahoma City, USA) |
| 14.05-14.15 | Panel Discussion |
| 14.15-14.20 | ECMELLA Cannulation G. Nersesian (Berlin, GER) |
| 14.20-14.30 | Panel Discussion |
| 14.30-14.35 | ECPELLA and Ventricular Fibrillation F. Pappalardo (Alessandria, IT) |
| 14.35-14.45 | Panel Discussion |
| 14.45-14.50 | Impella 5.5 Bridge to Mechanical Circulatory Support or Heart Transplantation D. Zimpfer (Graz, AUT) |
| 14.50-15.00 | Panel Discussion |
| 15.00-15.15 | Coffee Break |
| 15.05-16.45 | Session 2 - Challenges in Structural Heart Disease and Management of Heart Failure Moderator B. Sun Panel: B. Kar, A. Apor, A. Zirlik, J. Baranowski, U. Jorde, M. Patarroyo |
| 15.15-15.20 | A Case of Structural Intervention in Cardiogenic Shock B. Kar (Houston, TX) |
| 15.20-15.30 | Panel Discussion |
| 15.30-15.35 | Imaging of Structural Heart Disease Interventions A. Apor (Budapest, HUN) |
| 15.35-15.45 | Panel Discussion |
| 15.45-15.50 | Tricuspid Valve Replacement in Advanced Heart Failure A. Zirlik (Graz, AUT) |
| 15.50-16.00 | Panel Discussion |
| 16.00-16.05 | Percutaneous Mitral Valve Interventions J. Baranowski (Linkoping, SWE) |
| 16.05-16.15 | Panel Discussion |
| 16.15-16.20 | AccuCinch Ventricular Restoration System U. Jorde (New York, USA) |
| 16.20-16.30 | Panel Discussion |
| 16.30-16.35 | RELIEVE-HF: Interatrial Shunting M. Patarroyo (Houston, USA) |
| 16.35-16.45 | Panel Discussion |
| 16.45-17.00 | Coffee Break |
| 17.00-18.00 | Session 3 - End-stage Hear Failure Treatment Options and Dilemmas Moderator J. Kirklin Panel: N. Uriel, P. Mohacsi, B. Vrtovec, F. Pagani, U. Livi |
| 17.00-17.05 | Current Expectations with MCS and Heart Transplantation J. Kirklin (Birmingham, USA) |
| 17.05-17.15 | Panel Discussion |
| 17.15-17.20 | Should We Transplant Stable LVAD Patient? (Conditional Survival on HM3) N. Uriel (New York, USA) |
| 17.20-17.30 | Panel Discussion |
| 17.30-17.35 | New Ways to Manage Patients After Heart Transplantation P. Mohacsi (Zurich, SWI) |
| 17.35-17.45 | Panel Discussion |
| 17.45-17.50 | Stem Cells in Patients on LVAD Support B. Vrtovec (Ljubljana, SI) |
| 17.50-18.00 | Panel Discussion |
| 18.00-18.15 | Coffee Break |
| 18.15-19.15 | Session 4 - Improving Mechanical Circulatory Treatments in Heart Failure Moderator E. Potapov Panel: E. Rame, B. Meyns, M. Patarroyo, J. Patel |
| 18.15-18.20 | LVAD Therapy: From Partial Recovery to Full Remission to Explant E. Rame (Philadelphia, USA) |
| 18.20-18.30 | Panel Discussion |
| 18.30-18.35 | How to Increase Recovery in Patients on Impella 5.5 Support? B. Meyns (Leuven, BEL ) |
| 18.35-18.45 | Panel Discussion |
| 18.45-18.50 | Prehabilitation in Patient with Cardiogenic Shock Supported on Axillary Impella M. Patarroyo (Houston, USA) |
| 18.50-19.00 | Panel Discussion |
| 19.00-19.05 | Overcoming Obstacles During Impella 5.5 Implantation J. Patel (Houston, USA) |
| 19.05-19.15 | Panel Discussion |
| 08.30-10.15 | Session 5 - Update on Regional End Stage Heart Failure Programs Moderators: A. Zuckermann, B. Biocina, P. Przybylowski Panel: B. Sax, H. Gasparovic, D. Baric, I. Knezevic, S. Putnik, S. Borovic, A. Redzek, S. Jovev, M. Peric |
| 08.30-08.35 | Heart Transplantation and MCS at Semmelweis Institute, Budapest B. Sax (Budapest, HUN) |
| 08.35-08.40 | Q&A |
| 08.40-08.45 | Heart Transplantation and MCS at University Hospital Center, Zagreb H. Gasparovic (Zagreb, CRO) |
| 08.45-08.50 | Q&A |
| 08.50-08.55 | Heart Transplantation and MCS at Dubrava University Hospital, Zagreb D. Baric (Zagreb, CRO) |
| 08.55-09.00 | Q&A |
| 09.00-09.05 | Heart Transplantation and MCS at University Medical Center, Ljubljana I. Knezevic (Ljubljana, SLO) |
| 09.05-09.10 | Q&A |
| 09.10-09.15 | Heart Transplantation and MCS at Clinical Center Belgrade S. Putnik (Belgrade, SR) |
| 09.15.-09.20 | Q&A |
| 09.20-09.25 | MCS in ICVD Dedinje, Belgrade S. Borovic (Belgrade, SR) |
| 09.25-09.30 | Q&A |
| 09.30-09.35 | Heart Transplantation in IKVD Sremska Kamenica A. Redzek (Novi Sad, RS) |
| 09.35-09.40 | Q&A |
| 09.40-09.45 | Heart Transplantation in Skopje S. Jovev (Skopje, R.SM) |
| 09.45-09.50 | Q&A |
| 09.50.-10.15 | Panel Discussion |
| 10.15-10.30 | Coffee Break |
| 10.30-12.00 | Session 6 - Update on New LVADs on Horizon Moderator: J. Long Panel: O.H. Frazier, Y. Pya, R. Smalling, I. Netuka, P. Leprince |
| 10.30-10.35 | Innovations in Mechanical Circulatory Support J. Long (Oklahoma City, USA) |
| 10.35-10.45 | Panel Discussion |
| 10.45-10.50 | BiVACOR Inc O.H. Frazier (Houston, USA) |
| 10.50-11.00 | Panel Discussion |
| 11.00-11.05 | Biventricular Pulsatile Support (Carmat) Y. Pya (Astana, K) |
| 11.05-11.15 | Panel Discussion |
| 11.15-11.20 | TORVAD R. Smalling (Houston, USA) |
| 11.20-11.30 | Panel Discussion |
| 11.30-11.35 | Fully Inplantable LVAD (FineHeart) I. Netuka (Praha, CZ) |
| 11.35-11.45 | Panel Discussion |
| 11.45-11.50 | CorWave Membrane LVAD P. Leprince (Paris, FR) |
| 11.50-12.00 | Panel Discussion |
| 12.00-13.00 | Lunch Break |
| 13.00-14.15 | Session 7 - Pharmacological Therapies in Heart Failure Management Moderator: P. Mohacsi Panel: G. Poglajen, D. Feldman, J. Estep, A. Borbely, S. Frljak, D. Planinc |
| 13.00-13.05 | Vericiguat Therapy G. Poglajen (Ljubljana, SI) |
| 13.05-13.15 | Panel Discussion |
| 13.15-13.20 | The Updated HF Guidelines: Sacubitril/Valsartan D. Feldman (Minneapolis, USA) |
| 13.20-13.30 | Panel Discussion |
| 13.30-13.35 | SGLT2 Inhibitors J. Estep (Cleveland, USA) |
| 13.35-13.45 | Panel Discussion |
| 13.45-13.50 | Omecamtiv mecarbil A. Borbely (Debrecen, HUN) |
| 13.50-14.00 | Panel Discussion |
| 14.00-14.05 | Novel Therapeutic Options for ATTR Amyloidosis S. Frljak (Ljubljana, SI) |
| 14.05-14.15 | Panel Discussion |
| 14.15-14.30 | Coffee Break |
| 14.30-15.30 | Session 8 - Therapeutic options in patients with sustained and recurrent ventricular tachycardia Moderator: B. Merkely Panel: A. Kosztin, M. Imazio, R. Hariharan, G. Couper, F. Pappalardo |
| 14.30-14.35 | New Results in Cardiac Resynchronization Therapy in Heart Failure A. Kosztin (Budapest, HUN) |
| 14.35-14.45 | Panel Discussion |
| 14.45-14.50 | Pharmacological Treatment of Reccurent and Refractory Tachyarrhythmias M. Imazio (Trieste, IT) |
| 14.50-15.00 | Panel Discussion |
| 15.00-15.05 | Transcatheter Radiofrequency Ablation after Impella 5.5 Implant R. Hariharan (Houston, USA) |
| 15.05-15.15 | Panel Discussion |
| 15.15-15.20 | Pre-, Intra- and Post-Operative Management of Ventricular Tachycardia in Durable Left Ventricular Assist Device Therapy G. Couper (Boston, USA) |
| 15.20-15.30 | Panel Discussion |
| 15.30-16.00 | Dr. David Taylor Memorial Lecture |
| About Bringing Down the Cholesterol Levels of Entire Community J. Narula (Houston, USA) | |
| 16.00-16.15 | Coffee Break |
| 16.15-17.30 | Session 9 - Challenges in Mechanical Circulatory Support I Moderator: E. Rame Panel: M. Slepian, G. Wieselthaler, W. Dembitsky, V. Jeevanandam, M. Patel |
| 16.15-16.20 | Medical, Legal and Societal Implications of Field Consolidation in MCS - Consequences, Impact, Adapt, Act M. Slepian (Tucson , USA) |
| 16.20-16.30 | Panel Discussion |
| 16.30-16.35 | Optimizing Ventricular Assist Device Outcomes G. Wieselthaler (San Francisco, USA) |
| 16.35-16.45 | Panel Discussion |
| 16.45-16.50 | Pulsatile or No Pulsatile Blood Flow? W. Dembitsky (San Diego, USA) |
| 16.50-17.00 | Panel Discussion |
| 17.00-17.05 | Bloodless Advanced Congestive Heart Failure Therapy V. Jeevanandam (Chicago, USA) |
| 17.05-17.15 | Panel Discussion |
| 17.15-17.20 | Mechanical Circulatory Support in Pulmonary Embolism M. Patel (Houston, USA) |
| 17.20-17.30 | Panel Discussion |
| 17.30-17.45 | Coffee Break |
| 17.45-19.00 | Session 10 - Challenges in Mechanical Circulatory Support II Moderator: U. Jorde Panel: M. Guglin, T. Schloglhofer, A. Bracey, I. Hartyanzsky, E. Tuzun, Z. Trifunovic |
| 17.45-17.50 | Left Ventricular Assist Device in Fontan M. Guglin (Indianapolis, USA) |
| 17.50-18.00 | Panel Discussion |
| 18.00-18.05 | Left Ventricular Assist Devices Driveline Infections T. Schloglhofer (Vienna, AT) |
| 18.05-18.15 | Panel Discussion |
| 18.15-18.20 | Anticoagulation Challenges in Patients on ECMO A. Bracey (Houston, USA) |
| 18.20-18.30 | Panel Discussion |
| 18.30-18.35 | 3D Modeling in Heart Surgery I. Hartyanszky (Budapest, HUN) |
| 18.35-18.45 | Panel Discussion |
| 18.45-18.50 | David Surgery Facilitator for Patient Specific Aortic Root Replacement E. Tuzun (Istanbul, TUR) |
| 18.50-19.00 | Panel Discussion |
| 08.30-10.00 | Session 11 - Heart Failure Pathology and Diagnostics Moderator: A. Fintha Panel: N. Narula, C. Bödör, A. Segura, M. Zucker, J. Diez, F. Arabia, M. Nedeljkovic |
| 08.30-08.35 | If We Knew, Could We Have Prevented: Role of a Pathologist in the Transplant/VAD Center N. Narula (Houston, USA) |
| 08:35-08.45 | Panel Discussion |
| 08.45-08.50 | Next-Generation Sequencing and Other Advanced Technologies in Diagnostics of Heart Failure C. Bödör (Budapest, HUN) |
| 08.50-09.00 | Panel Discussion |
| 09.00-09.05 | Immune Checkpoint Inhibitor-Associated Myocarditis: Pathology A. Segura (Houston, USA) |
| 09.05-09.15 | Panel Discussion |
| 09.15-09.20 | Tyrosine Kinase Toxicity and Heart Disease M. Zucker (Newark, USA) |
| 09.20-09.30 | Panel Discussion |
| 09.30-09.35 | Oncologic Patients: the Many Faces of Cardiotoxicity J. Diez (Houston, USA) |
| 09:35-09:45 | Panel Discussion |
| 09:45-09:50 | Artificial Intelligence in Heart Failure Management F. Arabia (Phoenix, USA) |
| 09.50-10.00 | Panel Discussion |
| 10.00-10.15 | Coffee Break |
| 10.15-12.00 | Session 12 - Novel Technologies (Non CME Accredited Session) Chairs: W. Dembitsky, J. Long |
| 10.15-10.30 | Abbott |
| 10.30-10.35 | Q&A |
| 10.35-10.45 | Abbott |
| 10.45-10.55 | Q&A |
| 10.55-11.10 | Abiomed |
| 11.10-11.20 | Q&A |
| 11.20-11.35 | Paragonix |
| 11.35-11.40 | Q&A |
| 11.40-11.55 | Berlin Heal |
| 11.55-12.00 | Q&A |
| 12.00-13.00 | Lunch Break |
| 13.00-14.30 | Session 13 - Heart Transplantation New Allocation System and Outcomes Moderator: G. Dellgren Panel: S. Hunt, M. Johnson, D. Vega, C. Salerno, F. Pagani, H. Gasparovic |
| 13.00-13.20 | Norman Shumway Centenary Recognition S. Hunt (San Francisco, USA) |
| 13.20-13.30 | Panel Discussion |
| 13.30-13.35 | Waitlist Outcomes in the New Heart Allocation System Era M. Johnson (Madison, USA) |
| 13.35-13.45 | Panel Discussion |
| 13.45-13.50 | MCS Bridge to Transplant and New Allocation System D. Vega (Atlanta, USA) |
| 13.50-14.00 | Panel Discussion |
| 14.00-14.05 | HeartMate 3 or Heart Transplant: Adverse Events and Outcomes C. Salerno (Chicago, USA) |
| 14.05-14.15 | Panel Discussion |
| 14.15-14.20 | Comparison of LVAD and Transplant in Older Adults – Age 65 and Greater F. Pagani (Ann Arbour, USA) |
| 14.20-14.30 | Panel Discussion |
| 14.30-14.45 | Coffee Break |
| 14.45-16.15 | Session 14 - Challenges in Heart Transplantation Moderator: A. Zuckermann Panel: J. Kobashigawa, B. Sax, G. Dellgren, I. Knezevic, S. Putnik |
| 14.45-15.05 | Emerging Understanding of Antibodies and Antibody-Mediated Rejection in Heart Transplantation J. Kobashigawa (Los Angeles, USA) |
| 15.05-15.15 | Panel Discussion |
| 15.15-15.20 | Extracorporeal Photopheresis of Heart Transplant Recipients B. Sax (Budapest, HUN) |
| 15.20-15.30 | Panel Discussion |
| 15.30-15.35 | Heart Transplantation and Renal Function G. Dellgren (Gothenburg, SW) |
| 15.35-15.45 | Panel Discussion |
| 15.45-15.50 | Heart Re-Transplantation or BiVAD? I. Knezevic (Ljubljana, SI) |
| 15.50-16.00 | Panel Discussion |
| 16.00-16.15 | Coffee Break |
| 16.15-17.45 | Session 15 - Hot (Cold) Topics in Heart Transplantation Moderator: J. Stehlik Panel: A. Zuckermann, B. Sun, S. Sponga, S. Silvestry, S. Joseph |
| 16.15-16.30 | How to Start a DCD Heart Transplant Program A. Zuckermann (Vienna, AT) |
| 16.30-16.45 | Panel Discussion |
| 16.45-16.50 | TransMedics Cardiac Donor Organ Maintenance Systems B. Sun (Columbus, USA) |
| 16.50-17.00 | Panel Discussion |
| 17.00-17.05 | Warm or Cold? That is the Question S. Sponga (Udine, IT) |
| 17.05-17.15 | Panel Discussion |
| 17.15-17.20 | Primary Graft Dysfunction and Organ Maintenance S. Silvestry (Weston, USA) |
| 17.20-17.30 | Panel Discussion |
| 17.30-17.35 | Update on Xenotransplantation S. Joseph (Baltimore, USA) |
| 17.35-17.45 | Panel Discussion |
| 17.45-18.00 | Coffee Break |
| 18.00-19.00 | Session 16 - Management Following Heart Transplantation Moderator: J. Kobashigawa Panel: A. Fintha, J. Stehlik, G. Sayer, T. Teszak, Z. Sutlic |
| 18.00-18.05 | Molecular microscopy (MMDx) results correlating with histological and immunhistological findings of endomyocardial biopsies A. Fintha (Budapest, HUN) |
| 18.05-18.15 | Panel Discussion |
| 18.15-18.20 | SGLT2i - Potential benefits after Heart Transplant J. Stehlik (Salt Lake City, USA) |
| 18.20-18.30 | Panel Discussion |
| 18.30-18.35 | Managing Transplant in the Gene Expression and Cell Free DNA Era G. Sayer (New York, USA) |
| 18.35-18.45 | Panel Discussion |
| 18.45-18.50 | First European Experience in dd-cfDNA Surveillance of HT Recipients T. Teszak (Budapest, HUN) |
| 18.50-19.00 | Panel Discussion |
| 19.00-19.15 | Closing Remarks and Meeting Adjournment Moderators: I. Gregoric, B. Merkely, A. Zuckermann |